Prior authorization requirements, quantity limits, and step therapy protocols further restrict access for many enrollees
Visits, follow-up, shipping, and supplies can change the actual monthly total
[11] [12] Currently available GLP-1 receptor agonists in the United States include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide (Byetta, Bydureon BCise), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GLP-1/GIP receptor agonist
Following the initial dehydrogenation, the resulting long-chain enoyl-CoAs undergo hydration, a second dehydrogenation step, and finally thiolytic cleavage catalyzed by mitochondrial trifunctional protein (MTP) [10]
Add an extra walk, bump up workout intensity, or try a new type of exercise
The interaction between GIP and GLP-1 receptor pathways has been shown to result in improved glycaemic control and greater weight loss compared to semaglutide 1 mg in head-to-head clinical trials
